These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32881062)

  • 1. Hypothesis: The potential therapeutic role of nicorandil in COVID-19.
    Ashour H; Elsayed MH; Elmorsy S; Harb IA
    Clin Exp Pharmacol Physiol; 2020 Nov; 47(11):1791-1797. PubMed ID: 32881062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: Melatonin as a potential adjuvant treatment.
    Zhang R; Wang X; Ni L; Di X; Ma B; Niu S; Liu C; Reiter RJ
    Life Sci; 2020 Jun; 250():117583. PubMed ID: 32217117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
    Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Atrial Fibrillation in COVID-19 Pandemic.
    Hu YF; Cheng WH; Hung Y; Lin WY; Chao TF; Liao JN; Lin YJ; Lin WS; Chen YJ; Chen SA
    Circ J; 2020 Sep; 84(10):1679-1685. PubMed ID: 32908073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
    Seirafianpour F; Mozafarpoor S; Fattahi N; Sadeghzadeh-Bazargan A; Hanifiha M; Goodarzi A
    Dermatol Ther; 2020 Jul; 33(4):e13733. PubMed ID: 32473070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
    Taboada M; Caruezo V; Naveira A; Atanassoff PG
    J Clin Anesth; 2020 Nov; 66():109926. PubMed ID: 32474331
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
    Andreou A; Trantza S; Filippou D; Sipsas N; Tsiodras S
    In Vivo; 2020 Jun; 34(3 Suppl):1567-1588. PubMed ID: 32503814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
    Nisole S; Saulnier A; Gatignol A
    Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
    Benani A; Ben Mkaddem S
    Front Immunol; 2020; 11():1841. PubMed ID: 32793246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
    Menegazzi M; Campagnari R; Bertoldi M; Crupi R; Di Paola R; Cuzzocrea S
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic.
    Monji F; Al-Mahmood Siddiquee A; Hashemian F
    Eur J Pharmacol; 2020 Nov; 887():173561. PubMed ID: 32946870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis.
    José RJ; Williams A; Manuel A; Brown JS; Chambers RC
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33004529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapeutics for the management of COVID 19.
    Debnath SK; Srivastava R; Omri A
    Expert Opin Emerg Drugs; 2020 Sep; 25(3):337-351. PubMed ID: 32799566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for chronotherapy in Covid-19-induced acute respiratory distress syndrome.
    Tamimi F; Abusamak M; Akkanti B; Chen Z; Yoo SH; Karmouty-Quintana H
    Br J Pharmacol; 2020 Nov; 177(21):4845-4850. PubMed ID: 32442317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
    Yaqinuddin A; Kashir J
    Med Hypotheses; 2020 Oct; 143():109906. PubMed ID: 32505910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
    El-Missiry MA; El-Missiry ZMA; Othman AI
    Eur J Pharmacol; 2020 Sep; 882():173329. PubMed ID: 32615182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
    Nasiripour S; Zamani F; Farasatinasab M
    J Clin Pharmacol; 2020 Jul; 60(7):828-829. PubMed ID: 32445400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.